Johnson & Johnson Reaches Agreement with U.S. Government on Drug Price Cuts in Exchange for Tariff Exemptions
On January 8, Johnson & Johnson announced that it had reached an agreement with the Trump administra...
U.S. Food and Drug Administration (FDA) Approves Omeros' New Drug Yartemlea for the Treatment of Transplant Complication TA-TMA
Wedoany.com Report-Dec.31, The U.S. Food and Drug Administration (FDA) has officially approved Yarte...
Mabwell's Adalimumab Injection Approved for Marketing in Indonesia
Wedoany.com Report-Dec.31, Mabwell (688062.SH), an innovative biopharmaceutical company with a full ...
Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
Wedoany.com Report-Dec.30, Osaikang announced that its subsidiary Jiangsu Osaikang Pharmaceutical Co...
Ipsen Outlays $1BN for China-Based Simcere’s Preclinical ADC
Wedoany.com Report-Dec.28, Ipsen has entered into an exclusive licensing agreement with Simcere Zaim...
China’s Jacobio Inks Immuno-Oncology Deal Worth $1.9 B With AstraZeneca
Wedoany.com Report-Dec.26, China-based Jacobio Pharma (1167.HK) has entered into a global exclusive ...
Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan Ipark in Japan
Wedoany.com Report-Dec.26, Asahi Kasei Pharma Corporation has announced plans to relocate its R&...
US FDA Approves Omeros’ Drug to Treat Dangerous Transplant Complication
Wedoany.com Report-Dec.25, Omeros Corporation announced on Wednesday that the U.S. Food and Drug Adm...
Sanofi Pushes Ahead on Adult Vaccines With $2.2 Billion Dynavax Deal
Wedoany.com Report-Dec.25, Sanofi announced on Wednesday, December 24, 2025, that it has entered int...
Agios Pharma Shares Jump as US FDA Expands Approval for Blood Disorder Drug
Wedoany.com Report-Dec.25, Agios Pharmaceuticals announced late on Tuesday that the U.S. Food and Dr...
京公网安备 11010802043282号